|
FUNDC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.409700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.741800E-03 |
| Normal-vs-Stage2 |
6.618700E-04 |
| Normal-vs-Stage3 |
6.883100E-03 |
| Normal-vs-Stage4 |
9.379200E-03 |
| Stage1-vs-Stage2 |
2.044600E-01 |
| Stage1-vs-Stage3 |
6.676200E-01 |
| Stage1-vs-Stage4 |
9.087800E-01 |
| Stage2-vs-Stage3 |
4.836000E-01 |
| Stage2-vs-Stage4 |
3.685800E-01 |
| Stage3-vs-Stage4 |
8.171800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.560900E-04 |
| Normal-vs-AfricanAmerican |
4.164300E-02 |
| Normal-vs-Asian |
8.290600E-01 |
| Caucasian-vs-AfricanAmerican |
4.699000E-01 |
| Caucasian-vs-Asian |
3.941200E-01 |
| AfricanAmerican-vs-Asian |
7.145400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.35420000160858E-08 |
| Normal-vs-Female |
9.724200E-01 |
| Male-vs-Female |
1.2995049480935E-11 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.549600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.57950000000606E-05 |
| Normal-vs-Age(61-80Yrs) |
1.379530E-02 |
| Normal-vs-Age(81-100Yrs) |
7.307900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.791800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.304400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.676600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.262200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.018200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.828400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.358000E-01 |
| Normal-vs-Grade 2 |
1.068230E-02 |
| Normal-vs-Grade 3 |
1.341520E-03 |
| Normal-vs-Grade 4 |
1.563470E-04 |
| Grade 1-vs-Grade 2 |
6.062200E-01 |
| Grade 1-vs-Grade 3 |
3.913400E-01 |
| Grade 1-vs-Grade 4 |
1.344590E-01 |
| Grade 2-vs-Grade 3 |
3.364000E-01 |
| Grade 2-vs-Grade 4 |
6.578000E-02 |
| Grade 3-vs-Grade 4 |
3.445000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.431150E-04 |
| Normal-vs-ccB subtype |
2.624100E-02 |
| ccA subtype-vs-ccB subtype |
2.072200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.377620E-03 |
| Normal-vs-N1 |
7.176400E-02 |
| N0-vs-N1 |
7.528400E-01 |
|
|
